HIV-1 group O resistance pathway with raltegravir is similar to HIV-1 group M

AIDS. 2015 Jun 19;29(10):1271-3. doi: 10.1097/QAD.0000000000000703.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-HIV Agents / pharmacology*
  • Anti-HIV Agents / therapeutic use
  • Antiretroviral Therapy, Highly Active / methods
  • CD4 Lymphocyte Count
  • Drug Resistance, Viral*
  • Female
  • Genotype*
  • HIV Infections / drug therapy
  • HIV Infections / virology*
  • HIV Integrase / genetics
  • HIV-1 / classification*
  • HIV-1 / drug effects*
  • HIV-1 / genetics
  • HIV-1 / isolation & purification
  • Humans
  • Mutation, Missense
  • Raltegravir Potassium / pharmacology*
  • Raltegravir Potassium / therapeutic use
  • Treatment Outcome
  • Viral Load

Substances

  • Anti-HIV Agents
  • Raltegravir Potassium
  • HIV Integrase
  • p31 integrase protein, Human immunodeficiency virus 1